Imaging gene expression: Principles and assays

Journal of Nuclear Cardiology

Volumn 6, Issue 2, 1999, Pages 219-233

  Gambhir, S S ^a   Barrio, J R ^b   Herschman, H R ^b   Phelps, M E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

BIOASSAY; CARDIOVASCULAR DISEASE; DNA PROBE; GENE EXPRESSION; GENE INSERTION; GENE TARGETING; GENETIC ENGINEERING AND GENE TECHNOLOGY; GENETIC TRANSCRIPTION; HUMAN; IMAGING; ISOTOPE LABELING; NONHUMAN; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPORTER GENE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032937226     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(99)90083-1     Document Type: Article

References (70)

1. Haider N, Iyer RR, Marula J. Topics in molecular biology: techniques and methods. J Nucl Cardiol 1998;5:343-54.
2. Rolland AP. From genes to gene medicines: recent advances in nonviral gene delivery. Crit Rev Ther Drug Carrier Syst 1998;15:143-98.
3. Miller N, Vile R. Targeted vectors for gene therapy. FASEB J 1995;9:190-9.
4. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997;389:239-42.
5. Levenson VV, Transue ED, Roninson IB. Internal ribosomal entry sitecontaining retroviral vectors with green fluorescent protein and drug resistance markers. Human Gene Ther 1998;9:1233-6.
6. Lewin B. Genes V. New York: Oxford University Press; 1994.
7. Misteli T, Spector D. Applications of the green fluorescent protein in cell biology and biotechnology. Nat Biotechnol 1997;15:961-4.
8. Jacobs WR, Barletta RG, Udani R, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993;260:819-22.
9. Nishiyama T, Kawamura Y, Kawamoto Kea. Antineoplastic effects of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res 1985;45:1753-61.
10. Wallace PM, MacMaster JF, Smith VF, et al. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine. Cancer Res 1994;54:2719-23.
11. Haberkorn U, Oberdorfer F, Gebert J, et al. Monitoring of gene therapy with cytosine deaminase: in vitro studies using 3H-5-fluorocytosine. J Nucl Med 1996;37:87-94.
12. Tjuvajev J, Uehara H, Stockhammer G, et al. Monitoring gene therapy: imaging gene transfer and expression. J Cereb Blood Flow Metab 1995;15:S110.
13. Srinivasan A, Gambhir SS, Green LA, et al. A PET reporter gene (PRG)/PET reporter probe (PRP) technology for repeatedly imaging gene expression in living animals. J Nucl Med 1996;37:107P.
14. De Clercq E. Biochemical aspects of the selective antiherpes activity of nucleoside analogues. Biochem Pharmacol 1984;33:2159-69.
15. Oliver S, Bubley G. Inhibition of HSV-transformed murine cells by nucleoside analogs, 2′-NDG and 2″-nor-cGMP: mechanisms of inhibition and reversal by exogenous nucleosides. Virology 1985;145:84-93.
16. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for prospective cancer control strategy. Cancer Res 1986;46:5276-81.
17. Alrabiah FA, Sacks SL. New antiherpes virus agents: their targets and therapeutic potential. Drugs 1996;52:17-32.
18. Saito Y, Price RW, Rottenberg DA, et al. Quantitative autoradiographic mapping of herpes simplex virus encephalitis with radiolabeled antiviral drug. Science 1982;217:1151-3.
19. Saito Y, Rubenstein R, Price R, et al. Diagnostic imaging of herpes simplex virus encephalitis using antiviral drug: autoradiographic assessment in animal model. Ann Neurol 1984;15:548-58.
20. Price R, Cardle K, Watanabe K. The use of antiviral drugs to image herpes encephalitis. Cancer Res 1983;43:3619-27.
21. Tovell DR, Samuel J, Mercer JR, et al. The in vitro evaluation of nucleoside analogues as probes for use in the non-invasive diagnosis of herpes simplex encephalitis. Drug Des Deliv 1988;3:213-21.
22. Tjuvajev J, Stockhammer G, Desai R, et al. Imaging gene transfer and expression in vivo. Cancer Res 1995;55:6121-35.
23. Morin KW, Atrazheva ED, Knaus EE, et al. Synthesis and cellular uptake of 2′-substituted analogues of (E)-5-(2-[125I]iodovinyl-2′-deoxyuridine in tumor cells transduced with the herpes simplex type-1 thymidine kinase gene: evaluation as probes for monitoring gene therapy. J Med Chem 1997;40:2184-90.
24. Barrio JR, Namavari M, Srinivasan A, et al. Carbon-8 radiofluorination of purines: a general approach to probe design for gene therapy in humans. XIIth International Symposium on Radiopharmaceutical Chemistry. Uppsala, Sweden; 1997:348.
25. Barrio JR, Namavari M, Satyamurthy N, et al. 8-[F-18]fluoroacyclovir: an in vivo probe for gene expression with PET. J Nucl Med 1996;37:193P.
26. Barrio JB, Namavari M, Phelps ME, et al. Regioselective fluorination of substituted guanines with dilute F2: a facile entry of 8-fluoroguanine derivatives. J Organic Chem 1996;61:6084-5.
27. Barrio BR, Namavari M, Phelps ME, et al. Elemental fluorine to 8-fluorpurines in one step. J Am Chem Soc 1996;118:10408-11.
28. Monclus M, Luxen A, Van Naemen J, et al. Development of PET radiopharmaceuticals for gene therapy: synthesis of 9-((1-(18F)fluoro-3-hydroxy-2-propoxy)methyl) guanine. J Labeled Compound Radiopharm 1995;37:193-5.
29. Alauddin MM, Conti PS, Mazza SM, et al. Synthesis of 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]FHPG): A potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol 1996;23:787-92.
30. Tjuvajev JG, Stockhammer G, Desai R, et al. Imaging the expression of transfected genes in vivo. Cancer Res 1995;55:6126-32.
31. Tjuvajev JG, Finn R, Watanabe K, et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res 1996;56:4087-95.
32. Tjuvajev J, Avril N, Safer M, et al. Quantitative PET imaging of HSV1-TK gene expression with [I-124]FIAU. J Nucl Med 1997;38:239P.
33. Monclus M, Luxen A, Cool V, et al. Development of a positron emission tomography radiopharmaceutical for imaging thymidine kinase gene expression: synthesis and in vitro evaluation of 9-{3[18F]Fluoro-1-hydroxy-2-propoxy)methyl} guanine. Bioorganic Med Chem Lett 1997;7:1879-82.
34. Alauddin MM, Conti PS, Mazza SM, et al. Synthesis of F-18 9-[3-fluoro-1-hydroxy-2-propoxy)methyl]guanine (FHPG) for the in vivo imaging of viral infection and gene therapy with PET. J Nucl Med 1996;37:193P.
35. Alauddin MM, Conti PS. Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol 1998;25:175-80.
36. Gambhir SS, Barrio JR, Bauer E, et al. Radiolabeled penciclovir: a new reporter probe with improved imaging properties over ganciclovir for imaging herpes-simplex virus type 1 thymidine kinase reporter gene expression (abstract). J Nucl Med 1998;39:53P.
37. Gambhir SS, Barrio J, Wu L, et al. Imaging of adenoviral directed herpes simplex viras type 1 thymidine kinase gene expression in mice with ganciclovir. J Nucl Med 1998;39:2003-11.
38. Gambhir SS, Barrio JR, Phelps ME, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci (USA) 1999; 96:2333-8.
39. MacLaren DC, Gambhir SS, Satyamurthy N, et al. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Therapy (In press).
40. Barrio JB, Satyamurthy N, Huang SC, et al. 3-(2′-[18F]fluoroethyl)spiperone: In vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans. J Cereb Blood Flow Metab 1989;9:830-9.
41. MacLaren DC, Gambhir SS, Cherry SR, et al. Repetitive and Non-invasive in vivo imaging of reporter gene expression using adenovirus delivered dopamine D2 receptor as a PET reporter gene and FESP as a PET reporter probe. J Nucl Med 1998;39:35P.
42. Bogdanov A, Weissleder R. The development of in vivo imaging systems to study gene expression. Trends Biotechnol 1998;16:5-10.
43. Gambhir SS, Barrio JR, Herschman HR, et al. Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol (In press).
44. Hargrove JL, Hulsey MG, Schmidt FH, et al. A computer program for modeling kinetics of gene expression. Biotechniques 1990;8:654-60.
45. Crooke ST, Lebleu B. Antisense research and applications. Ann Arbor: CRC Press; 1993:579.
46. Cazenave C, Helene C. Antisense obgonucleotides. In: Mol JNM, Vander Krol AR, eds. Antisense nucleic acids and proteins: fundamentals and applications. New York: Marcel Dekker; 1991:47
47. Goodchild J. Oligodeoxynucleotides: antisense inhibitors of gene expression. London: Macmillan; 1989.
48. Pan D, Gambhir SS, Toyokuni T, et al. Rapid synthesis of a 5′-fluorinated oligodeoxynucletoide: a model antisense probe for use in imaging with positron emission tomography (PET). Bioorg Med Chem Lett 1998;8:1317-20.
49. Wickstrom E. Oligodeoxynucleotide stability in subcellular extracts and culture media. J Biochem Biophys Methods 1986;13:97-102.
50. Agrawal S, Iyer RP. Perspectives in antisense therapeutics. Pharmacol Therap 1997;56:151-60.
51. Crooke S. Progress in antisense therapeutics discovery and development. Ciba Foundation Symposium 1997;209:158-68.
52. Good L, Nielsen PE. Progress in developing PNA as a gene-targeted drug. Antisense and Nucleic Acid Drug Dev 1997;7:431-7.
53. Loke SL, Stein CA, Zhang XH, et al. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 1989;86:7595-9.
54. Cotten M, Wagner E, Birnstiel M. Receptor-mediated transport of DNA into eukaryotic cells. Methods Enzymol 1993;217:618-44.
55. Wu-Pong S, Weiss TL, Hunt AC. Antisense c-myc oligonucleotide cellular uptake and activity. Antisense Res Dev 1994;4:155-63.
56. Wu-Pong S, Weiss TL, Hunt AC. Antisense c-myc oligodeoxyribonucleotide cellular uptake. Pharm Res 1992;9:1010-7.
57. Crooke ST. Progress in antisense therapeutics. Hematol Pathol 1995;9:59-72.
58. Phillips JA, Craig SJ, Bayley D, et al. Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846A) after intravenous and subcutaneous administration. Biochem Pharmacol 1997;54:657-68.
59. Dewanjee MK, Ghafouripour AK, Kapadvanjwala M, et al. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J Nucl Med 1994;35:1054-63.
60. Hnatowich DJ, Winnard Pi, Virzi F, et al. Technetium-99m labeling of DNA oligonucleotides. J Nucl Med 1995;36:2306-14.
61. Cammilleri S, Sangrajrang S, Perderau B, et al. Biodistribution of iodine-125 tyramine transforming growth factor alpha antisense oligonucleotide in athymic mice with a human mammary tumor xenograft following intratumoral injection. Eur J Nucl Med 1996;23:448-52.
62. Tavitian B, Terrazzino S, Kühnast B, et al. In vivo imaging of oligonucleotides with positron emission tomography. Nature Med 1998;4:467-71.
63. Conrad RC, Baskerville S, Ellington AD. In vitro selection methodologies to probe RNA function and structure. Mol Divers 1995;1:69-78.
64. Charlton J, Sennello J, Smith D. In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase. Chem Biol 1997;4:809-16.
65. Haller M, Maasch C, Dragun D, et al. Antisense oligodeoxynucleotide strategies in renal and cardiovascular disease. Kidney Int 1998;53:1550-8.
66. Guzman RJ, Hirschowitz EA, Brody SL, et al. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci 1994;91:10732-6.
67. Franz WM, Mueller OJ, Hartong R, et al. Transgenic animal models: new avenues in cardiovascular physiology. J Mol Med 1997;75:115-29.
68. Cherry SR, Shao Y, Silverman RW, et al. MicroPET: a high resolution PET scanner for imaging small animals. IEEE Trans Nucl Sci 1997;44:1161-6.
69. Shao Y, Cherry SR, Farahani K, et al. Development of a PET detector system compatible with MRI/NMR systems. IEEE Trans Nucl Sci 1997;44:1167-71.
70. Kastis GK, Barber HB, Barrett HH, et al. High resolution SPECT imager for three-dimensional imaging of small animals [abstract]. 1998;39:9P.